Chukwunalu, O., Ambrósio, A. F., Carvalho, A. L., Quinn, P. M. J., Marques, J. P., & Alves, C. H. (2025). Genetic Landscape of Nonsyndromic Retinitis Pigmentosa in Portugal. Retinal Degenerative Diseases XX, 81–86. https://doi.org/10.1007/978-3-031-76550-6_14

da Costa, B. L., Caruso, S. M., Tsai, Y.-T., Castillejos, D. S., Sylla, M., Tsang, S. H., & Quinn, P. M. J. (2025). Prime Editing Strategy to Install the RPE65 c.1430A>G Dominant Mutation. Retinal Degenerative Diseases XX, 101–106. https://doi.org/10.1007/978-3-031-76550-6_17

da Costa, B. L., Pincay, J., Brodie, S. E., Tsang, S. H., & Quinn, P. M. J. (2025). Prime Editing Strategy to Install the Mfrp Retinal Degeneration 6 Mutation. Retinal Degenerative Diseases XX, 113–118. https://doi.org/10.1007/978-3-031-76550-6_19

Stehle, I. F., Imventarza, J. A., Woerz, F., Hoffmann, F., Boldt, K., Beyer, T., Quinn, P. M., & Ueffing, M. (2024). Human CRB1 and CRB2 form homo- and heteromeric protein complexes in the retina. Life Science Alliance, 7(6), e202302440. https://doi.org/10.26508/lsa.202302440

Nolan, N. D., Cui, X., Robbings, B. M., Demirkol, A., Pandey, K., Wu, W.-H., Hu, H. F., Jenny, L. A., Lin, C.-S., Hass, D. T., Du, J., Hurley, J. B., & Tsang, S. H. (2024). CRISPR editing of anti-anemia drug target rescues independent preclinical models of retinitis pigmentosa. Cell Reports Medicine, 5(4), 101459. https://doi.org/10.1016/j.xcrm.2024.101459

Malik, M. A., Saqib, M. A. N., Mientjes, E., Acharya, A., Alam, M. R., Wallaard, I., Schrauwen, I., Bamshad, M. J., Santos-Cortez, R. L. P., Elgersma, Y., Leal, S. M., & Ansar, M. (2023). A loss of function variant in AGPAT3 underlies intellectual disability and retinitis pigmentosa (IDRP) syndrome. European Journal of Human Genetics, 31(12), 1447–1454. https://doi.org/10.1038/s41431-023-01475-w

Caruso, S. M., Tsai, Y.-T., da Costa, B. L., Kolesnikova, M., Jenny, L. A., Tsang, S. H., & Quinn, P. M. J. (2023). Prime Editing Strategy to Install the PRPH2 c.828+1G>A Mutation. Retinal Degenerative Diseases XIX, 97–102. https://doi.org/10.1007/978-3-031-27681-1_15

da Costa, B. L., Li, Y., Levi, S. R., Tsang, S. H., & Quinn, P. M. J. (2023). Generation of CRB1 RP Patient-Derived iPSCs and a CRISPR/Cas9-Mediated Homology-Directed Repair Strategy for the CRB1 c.2480G>T Mutation. Retinal Degenerative Diseases XIX, 571–576. https://doi.org/10.1007/978-3-031-27681-1_83

Nolan, N. D., Jenny, L. A., Tsang, S. H., & Cui, X. (2023). Rod Photoreceptor-Specific Ablation of Metformin Target, AMPK, in a Preclinical Model of Autosomal Recessive Retinitis Pigmentosa. Retinal Degenerative Diseases XIX, 403–408. https://doi.org/10.1007/978-3-031-27681-1_59

Soucy, M., Kolesnikova, M., Kim, A. H., & Tsang, S. H. (2023). Phenotypic variability in PRPH2 as demonstrated by a family with incomplete penetrance of autosomal dominant cone-rod dystrophy. Documenta Ophthalmologica, 146(3), 267–272. https://doi.org/10.1007/s10633-022-09916-5

Tran, M., Kolesnikova, M., Kim, A. H., Kowal, T., Ning, K., Mahajan, V. B., Tsang, S. H., & Sun, Y. (2022). Clinical characteristics of high myopia in female carriers of pathogenic RPGR mutations: a case series and review of the literature. Ophthalmic Genetics, 44(3), 295–303. https://doi.org/10.1080/13816810.2022.2113544

Kim, A. H., Kolesnikova, M., Ngo, W. K., & Tsang, S. H. (2023). Effects of medications on hypoxia‐inducible factor in the retina: A review. Clinical & Experimental Ophthalmology, 51(3), 205–216. Portico. https://doi.org/10.1111/ceo.14161

Huang, W.-C., Liu, P.-K., & Wang, N.-K. (2022). Electroretinogram (ERG) to Evaluate the Retina in Cases of Retinitis Pigmentosa (RP). Retinitis Pigmentosa, 111–122. https://doi.org/10.1007/978-1-0716-2651-1_10

Ngo, W. K., Jenny, L. A., Kim, A. H., Kolesnikova, M., Greenstein, V. C., & Tsang, S. H. (2023). Correlations of Full-Field Stimulus Threshold With Functional and Anatomical Outcome Measurements in Advanced Retinitis Pigmentosa. American Journal of Ophthalmology, 245, 155–163. https://doi.org/10.1016/j.ajo.2022.07.010

Travor, M. D. (2022). Preclinical Models of Retinitis Pigmentosa. Retinitis Pigmentosa, 181–215. https://doi.org/10.1007/978-1-0716-2651-1_19

Thenappan, A. (2022). Current Management Options for Patients with Retinitis Pigmentosa. Retinitis Pigmentosa, 353–361. https://doi.org/10.1007/978-1-0716-2651-1_32

Kim, H. M., Oh, J. K., & Tsang, S. H. (2022). The Use of Optical Coherence Tomography in Evaluation of Retinitis Pigmentosa. Retinitis Pigmentosa, 91–100. https://doi.org/10.1007/978-1-0716-2651-1_8

Soucy, M., Tanaka, A. J., & Dharmadhikari, A. (2022). Molecular Genetic Testing Approaches for Retinitis Pigmentosa. Retinitis Pigmentosa, 41–66. https://doi.org/10.1007/978-1-0716-2651-1_4

Scherbakova, I., Ragi, S. D., & Sharma, T. (2022). Ocular Injection Techniques for Retinitis Pigmentosa: Intravitreal, Subretinal, and Suprachoroidal. Retinitis Pigmentosa, 375–392. https://doi.org/10.1007/978-1-0716-2651-1_34

Cho, A. (2022). Vector Shedding and Immunogenicity Sampling in AAV-Based Gene Therapy for Retinitis Pigmentosa Patients. Retinitis Pigmentosa, 347–352. https://doi.org/10.1007/978-1-0716-2651-1_31

Oh, J. K., Ryu, J., & Tsang, S. H. (2022). Fundus Photography Methodologies to Assess RP Patients. Retinitis Pigmentosa, 81–90. https://doi.org/10.1007/978-1-0716-2651-1_7

Breazzano, M. P., Grewal, M. R., Tsang, S. H., & Chen, R. W. S. (2022). Etiology of Retinitis Pigmentosa. Retinitis Pigmentosa, 15–30. https://doi.org/10.1007/978-1-0716-2651-1_2

Chang, A. Y. (2022). Challenges of Treatment Methodologies and the Future of Gene Therapy and Stem Cell Therapy to Treat Retinitis Pigmentosa. Retinitis Pigmentosa, 363–374. https://doi.org/10.1007/978-1-0716-2651-1_33

Cui, X., Chang, Y.-J., Jenny, L. A., Levi, S. R., Du, J., & Tsang, S. H. (2022). Metabolite Extraction from RPE Cells and Retinas Related to Retinitis Pigmentosa. Retinitis Pigmentosa, 257–265. https://doi.org/10.1007/978-1-0716-2651-1_24

Diaconita, V., Kassotis, A., & Ngo, W. K. (2022). Optical Coherence Tomography Angiography (OCTA) Findings in Retinitis Pigmentosa. Retinitis Pigmentosa, 101–109. https://doi.org/10.1007/978-1-0716-2651-1_9

Scherbakova, I., & Ragi, S. D. (2022). Pedigree Analysis of Families and Patients Affected by Retinitis Pigmentosa. Retinitis Pigmentosa, 67–71. https://doi.org/10.1007/978-1-0716-2651-1_5

Wang, H.-H., Chen, N., & Wang, N.-K. (2022). Introduction and Discovery of Retinitis Pigmentosa. Retinitis Pigmentosa, 1–14. https://doi.org/10.1007/978-1-0716-2651-1_1

Chen, N., Lee, H., Kim, A. H., Liu, P.-K., Kang, E. Y.-C., Tseng, Y.-J., Seo, G. H., Khang, R., Liu, L., Chen, K.-J., Wu, W.-C., Hsiao, M.-C., & Wang, N.-K. (2022). Case report: novel PCDH15 variant causes usher syndrome type 1F with congenital hearing loss and syndromic retinitis pigmentosa. BMC Ophthalmology, 22(1). https://doi.org/10.1186/s12886-022-02659-6

Ruff, A., Tezel, A., & Tezel, T. H. (2022). Anatomical and functional correlates of cystic macular edema in retinitis pigmentosa. PLOS ONE, 17(10), e0276629. https://doi.org/10.1371/journal.pone.0276629

O’Grady, L., Schrier Vergano, S. A., Hoffman, T. L., Sarco, D., Cherny, S., Bryant, E., Schultz‐Rogers, L., Chung, W. K., Sacharow, S., Immken, L. L., Holder, S., Blackwell, R. R., Buchanan, C., Yusupov, R., Lecoquierre, F., Guerrot, A., Rodan, L., de Vries, B. B. A., Kamsteeg, E. J., … Gold, N. B. (2022). Heterozygous variants in PRPF8 are associated with neurodevelopmental disorders. American Journal of Medical Genetics Part A, 188(9), 2750–2759. Portico. https://doi.org/10.1002/ajmg.a.62772

Cui, X., Kim, H. J., Cheng, C.-H., Jenny, L. A., Lima de Carvalho, J. R., Chang, Y.-J., Kong, Y., Hsu, C.-W., Huang, I.-W., Ragi, S. D., Lin, C.-S., Li, X., Sparrow, J. R., & Tsang, S. H. (2022). Long-term vitamin A supplementation in a preclinical mouse model forRhoD190N-associated retinitis pigmentosa. Human Molecular Genetics, 31(14), 2438–2451. https://doi.org/10.1093/hmg/ddac032

Wu, W.-H., Tsai, Y.-T., Huang, I.-W., Cheng, C.-H., Hsu, C.-W., Cui, X., Ryu, J., Quinn, P. M. J., Caruso, S. M., Lin, C.-S., & Tsang, S. H. (2022). CRISPR genome surgery in a novel humanized model for autosomal dominant retinitis pigmentosa. Molecular Therapy, 30(4), 1407–1420. https://doi.org/10.1016/j.ymthe.2022.02.010

Kajtna, J., Tsang, S. H., & Koch, S. F. (2022). Late-stage rescue of visually guided behavior in the context of a significantly remodeled retinitis pigmentosa mouse model. Cellular and Molecular Life Sciences, 79(3). https://doi.org/10.1007/s00018-022-04161-0

Nolan, N. D., Caruso, S. M., Cui, X., & Tsang, S. H. (2022). Renormalization of metabolic coupling treats age-related degenerative disorders: an oxidative RPE niche fuels the more glycolytic photoreceptors. Eye, 36(2), 278–283. https://doi.org/10.1038/s41433-021-01726-4